Inactive Instrument

CardioDx Inc Stock

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

CardioDx : New Study Published in The American Journal of Medicine Expands the Clinical Evidence Underscoring the Value of the Corus® CAD Blood Test to Help Safely Direct Cardiovascular Care	17-04-12	PU
CardioDx : Announces Results of Study Demonstrating the Benefits of the Corus CAD Gene Expression Test Use in an African American Patient Population	14-10-22	PU
CardioDx : Announces Aetna and Coventry Health Coverage for Corus® CAD Gene Expression Test	14-07-07	PU
CardioDx : New Study Results Further Reinforce that the Corus® CAD Test Helps Primary Care Clinicians Make Effective Referral Decisions for Patients with Suspected Obstructive Coronary Artery Disease	14-05-08	PU
CardioDx : and Medison Israel Enter Into an Exclusive Corus® CAD Product Marketing and Sales Agreement	14-04-09	PU

Sector

	1st Jan change	Capi.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-12.75%	7.4B
DIASORIN S.P.A.	+2.79%	5.47B
AUTOBIO DIAGNOSTICS CO., LTD.	-1.37%	4.51B
LANTHEUS HOLDINGS, INC.	+3.89%	4.42B
10X GENOMICS, INC.	-50.71%	3.29B
ANDON HEALTH CO., LTD.	+9.29%	2.66B
VITROLIFE AB	-14.69%	2.07B
MYRIAD GENETICS, INC.	-2.82%	1.68B
GUANGZHOU WONDFO BIOTECH CO.,LTD	-14.72%	1.66B